Heterocyclic compounds and thrombopoietin receptor activators

Details Heterocyclic compounds and thrombopoietin receptor activators Heterocyclic compounds and thrombopoietin receptor activators

2008-04-01

2008-04-01

Anderson, Rebecca (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S068000, C549S070000, C549S074000, C549S078000, C549S080000, C514S445000, C514S446000, C514S447000, C514S448000

Reexamination Certificate

active

11294609

ABSTRACT:
A compound represented by the formula (1):wherein A is a nitrogen atom or CR4, B is an oxygen atom, a sulfur atom or NR9(provided that when A is a nitrogen atom, B is not NH), R1is a C2-14aryl group, L1is a bond, CR10R11, an oxygen atom, a sulfur atom or NR12, X is OR13SR13or NR14NR15, R2is a hydrogen atom, a formyl group, a C1-10alkyl group or the like, L2is a bond or the like, L3is a bond, CR17R18, an oxygen atom, a sulfur atom or NR19, L4is a bond, CR20R21, an oxygen atom, a sulfur atom or NR22, Y is an oxygen atom, a sulfur atom or NR23, and R3is a C2-14aryl group, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

REFERENCES:
patent: 6720345 (2004-04-01), Luengo et al.
patent: 2004/0058990 (2004-03-01), Duffy et al.
patent: 2006/0094694 (2006-05-01), Owada, et al.
patent: 0258 182 (1988-03-01), None
patent: 01/34585 (2001-05-01), None
patent: 02/49413 (2002-06-01), None
patent: WO 02/49413 (2002-06-01), None
patent: WO 02/085343 (2002-10-01), None
patent: WO 2004/033433 (2004-04-01), None
Mohareb et al., CA 133:73973, 1998.
O'Mant, CA 69:27141, 1968.
van den Oudenrijn, Thromobopoietin Receptor, retieved Jan. 18, 2007 from Internet, <http://mmpr.nci.nih.gov/prow/guide/11586825—g.htm>, Protein Reviews On the Web, p. 1-6.
Wood, Thrombopoietin, Sep. 10, 1998, New England Journal of Medicine, p. 746-754.
U.S. Appl. No 11/721,786, filed Jun. 14, 2007, Miyaji, et al.
U.S. Appl. No 11/721,252, filed Jun. 8, 2007, Miyaji, et al.

Affiliated with

Also associated with

Rating

Heterocyclic compounds and thrombopoietin receptor activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds and thrombopoietin receptor activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and thrombopoietin receptor activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3943986